糖脉康对糖耐量减退者胰岛素敏感性的影响  

The Effects of Tangmaikang on Insulin Action Index(IAI) in Impaired Glucose Tolerance

作　　者：左文标[1] 张春香[1] 张庆涛[1] 

机构地区：[1]中国人民解放军第97医院内分泌科,江苏省徐州市221138

出　　处：《实用心脑肺血管病杂志》2006年第1期48-49,共2页Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease

摘　　要：目的了解糖脉康对糖耐量减退(IGT)者胰岛素敏感性的影响。方法将80例IGT患者随机分为对照组和治疗组,每组40例,在基础治疗的同时,对照组给予二甲双胍,治疗组给予糖脉康,观察两组治疗前后血糖、胰岛素、胰岛素敏感性指数(ISI)。结果两组治疗前后餐后血糖、空腹胰岛素、餐后胰岛素、ISI均较治疗前显著改善(P<0·01),两组间比较差别无显著性意义(P>0·05)。结论糖脉康可改善糖耐量减退患者的胰岛素敏感性。Objective To explore the effects of Tangmaikang on insulin action index in impaired glucose toleracnce （IGT）. Methods 80 patients with IGT were randomly divided into control group and treated group. Each group had 40 cases. Besides primary treatment, the control group was accepted mefformin, and the treated group was accepted Tangmaikang. The concentration of blood glucose, insulin, ISI were detected before and after treatment. Results The postprandial blood glucose, the fasting insulin, the postprandial insulin and ISI in two group were improved significantly before and after treatment （ P 〈 0. 01 ）, there was no significant different between two groups （ P 〉0. 05 ）. Conclusion Tangmaikang can improve insulin action index in impaired glucose tolerance.

关 键 词：糖脉康 胰岛素 糖耐量减退 

分 类 号：R587[医药卫生—内分泌]